Prime Medicine, Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of December 2024: 3.08x

Prime Medicine, Inc. Common Stock cash flow reinvestment rate. Prime Medicine, Inc. Common Stock (PRME) has a Cash Flow Reinvestment Rate of 3.08x as of December 2024, reinvesting $50.04 Million (capex $1.79 Million plus investments $48.25 Million) from operating cash flow of $16.25 Million. Explore Prime Medicine, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

3.08x
(Capex + Investments) / Operating CF

Total Reinvested

$50.04 Million
Capex + Investments

Operating Cash Flow

$16.25 Million
USD

Capital Expenditures

$1.79 Million
USD

Prime Medicine, Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)

Prime Medicine, Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Prime Medicine, Inc. Common Stock. For the full cash flow conversion analysis, see PRME cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow